| A Multi-institutional Study Analyzing Effect of Prophylactic Medication for Prevention of Opioid-induced Gastrointestinal Dysfunction. | |
| | |
MedLine Citation:
|
PMID: 22156893 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
OBJECTIVES:: The aim of this study was to evaluate the effectiveness of prophylactic treatment with laxatives and antiemetics on the incidence of gastrointestinal adverse reactions such as constipation, nausea and vomiting in cancer patients who received oral opioid analgesics for the first time. METHODS:: A multi-institutional retrospective study was carried out, in which 619 eligible hospitalized patients receiving oral opioid analgesics for cancer pain were enrolled from 35 medical institutions. The primary endpoint was the incidence of opioid-induced side effects in patients receiving prophylactic medication. Odds ratios of the incidence of adverse reactions in the absence or presence of premedication obtained from several institutions were subjected to a meta-analysis. RESULTS:: Among 619 patients, the incidence of constipation was significantly lower in patients receiving laxatives, including magnesium oxide, as premedication than in those without them (34% vs. 55%, odds ratio=0.432, 95% confidence interval=0.300-0.622, P<0.001). However, the incidence of nausea or vomiting was similar regardless of prophylactic medication with dopamine D2 blockers. The results of the meta-analysis revealed that prophylactic laxatives significantly reduced the incidence of constipation (overall odds ratio=0.469, 95% confidence interval=0.231-0.955, P=0.037), whereas dopamine D2 blockers were not effective in preventing opioid-induced nausea or vomiting. DISCUSSION:: We showed evidence for the effectiveness of premedication with laxatives for prevention of opioid-induced constipation. However, premedication with dopamine D2 blockers was not sufficient to prevent nausea or vomiting. |
| | |
Authors:
|
Masashi Ishihara; Hiroaki Ikesue; Hisashi Matsunaga; Katsuya Suemaru; Kiyoyuki Kitaichi; Kimitaka Suetsugu; Ryozo Oishi; Toshiaki Sendo; Hiroaki Araki; Yoshinori Itoh; |
Related Documents
:
|
21999763 - Best practices to reduce the risk of drug-drug interactions: opportunities for managed ... 21788893 - Polypharmacy and medication-related complications in the chronic kidney disease patient. 19697103 - Ethical problems in radiology: medical error and disclosure. |
Publication Detail:
|
Type: JOURNAL ARTICLE Date: 2011-12-7 |
Journal Detail:
|
Title: The Clinical journal of pain Volume: - ISSN: 1536-5409 ISO Abbreviation: - Publication Date: 2011 Dec |
Date Detail:
|
Created Date: 2011-12-13 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 8507389 Medline TA: Clin J Pain Country: - |
Other Details:
|
Languages: ENG Pagination: - Citation Subset: - |
Affiliation:
|
*Department of Pharmacy, Gifu University Hospital, Yanagido, Gifu †Department of Pharmacy, Kyushu University Hospital, Maidashi, Fukuoka ‡Department of Pharmacy, Okayama University Hospital, Shikata-cho, Okayama §Department of Pharmacy, Ehime University Hospital, Shizukawa, Toon, Japan. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: A Double-blind, Placebo-controlled Study on the Effect of Buprenorphine and Fentanyl on Descending P...
Next Document: Which algorithm should be used to screen for syphilis?